Showing 1841-1850 of 18601 results for "".
ADHD and the Presence of High IQ
https://reachmd.com/programs/clinicians-roundtable/adhd-and-the-presence-of-high-iq/2397/Traditional wisdom says that people with ADHD have lower IQs. Is it possible to have ADHD and a high IQ? Syracuse University psychologist Dr. Kevin Antshel joins host Dr. Leslie Lundt to discuss twice exceptional children.Navigating Genetic Testing in Kidney Transplants: Clinical and Ethical Issues
https://reachmd.com/programs/clinicians-roundtable/navigating-genetic-testing-in-kidney-transplants-clinical-and-ethical-issues/37222/Genetic testing is becoming an essential tool in kidney transplant evaluation and living donor screening, with APOL1 testing gaining traction for identifying post-donation risk. However, this evolving practice raises complex ethical and logistical challenges, as discussed by Dr. Elisa Gordon at theThe Activation of Itch
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37141/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, discusses the mechanism of itch.Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
https://reachmd.com/programs/neurofrontiers/genetic-pathways-in-ms-the-clinical-impact-of-a-chromosome-2-variant/32820/In a landmark study involving over 10,000 patients, the International MS Genetics Consortium (IMSGC) has identified the first genetic variant associated with disease severity in multiple sclerosis (MS). Dr. Sergio Baranzini, a Distinguished Professor of Neurology at the University of CalifornInnovations in IgAN Care: Addressing Challenges with Therapeutic Advances
https://reachmd.com/programs/clinicians-roundtable/innovations-in-igan-care-addressing-challenges-with-therapeutic-advances/37217/The available treatment options and even the current guidelines for the management of IgA nephropathy (IgAN) come with several limitations. Fortunately, new therapies are on the horizon that can help us address those challenges and slow disease progression in IgAN. Here with Dr. Charles Turck to disNavigating Treatment Goals in IgAN: The Impact of ET-1 and Ang II
https://reachmd.com/programs/clinicians-roundtable/navigating-treatment-goals-in-igan-the-impact-of-et-1-and-ang-ii/37214/Given that the endothelin-1 (ET-1) and angiotensin II (Ang II) pathways contribute to the pathogenesis of IgA nephropathy (IgAN), it’s important to set treatment goals that prevent disease progression. Joining Dr. Charles Turck to discuss the role and impacts of ET-1 and Ang II and how we can achievEquitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
https://reachmd.com/programs/heart-matters/equitable-care-for-attr-cm-improving-early-diagnosis-in-high-risk-groups/36142/Early detection of transthyretin amyloid cardiomyopathy (ATTR-CM), particularly in high-risk populations, requires a multifaceted approach that combines community-based interventions, collaboration across specialties, and technological integration. Join Dr. Kevin Alexander, an Assistant Professor ofImproving Postoperative Wound Outcomes Through Patient-Centered Education and Systemic Tools
https://reachmd.com/programs/clinicians-roundtable/improving-postoperative-wound-outcomes-through-patient-centered-education-and-systemic-tools/35839/Gaps in patient education and care coordination after surgery often hinder postoperative wound recovery. Join Dr. Karen Bauer as she discusses the importance of health literacy, access, and evidence-based care algorithms in engaging patients and support systems across the continuum. Dr. Bauer is a cManaging MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
https://reachmd.com/programs/frontlines-multiple-sclerosis/managing-ms-related-fatigue-with-therapeutic-lifestyle-and-behavioral-interventions/32665/Here’s how certain therapies, exercise, and reward-based interventions may be able to help address the unique nature of MS-related fatigue.Inflammatory Breast Cancer: A New Scoring System Proposed
https://reachmd.com/programs/project-oncology/inflammatory-breast-cancer-a-new-scoring-system-proposed/16253/Researchers are working on validating a new scoring system for inflammatory breast cancer. Here’s what to know.